Earnings Call · Q1 FY2022·2022-05-03

Q1 22EPS -31.03%·Rev n/aQ4 21EPS +20.00%·Rev n/aQ3 21EPS -50.00%·Rev n/aQ2 21EPS +19.23%·Rev n/a⚠ consensus missing

Lantern Pharma Inc. LTRN

Nicole Leber — Investor Relations

Panna Sharma — Chief Executive Officer

Kishor Bhatia — Chief Medical Officer

David Margrave — Chief Financial Officer

+2.1%1d on move date−0.9% vs SPY3d+1.5%5d−4.0%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more LTRN calls or request research access.

More LTRN calls Browse calls Request research access